Follow
Sara Clohisey Hendry
Sara Clohisey Hendry
Other namesSara Clohisey, Sara M Clohisey, Sara MR Clohisey
Verified email at roslin.ed.ac.uk - Homepage
Title
Cited by
Cited by
Year
Genetic mechanisms of critical illness in COVID-19
E Pairo-Castineira, S Clohisey, L Klaric, AD Bretherick, K Rawlik, D Pasko, ...
Nature 591 (7848), 92-98, 2021
13512021
Microglial brain region− dependent diversity and selective regional sensitivities to aging
K Grabert, T Michoel, MH Karavolos, S Clohisey, JK Baillie, MP Stevens, ...
Nature neuroscience 19 (3), 504-516, 2016
11072016
SARS-CoV-2 Omicron-B. 1.1. 529 leads to widespread escape from neutralizing antibody responses
W Dejnirattisai, J Huo, D Zhou, J Zahradník, P Supasa, C Liu, ...
Cell 185 (3), 467-484. e15, 2022
9272022
Mapping the human genetic architecture of COVID-19
Writing group Writing group leaders Pathak Gita A. 6 Andrews Shea J. 7 Kanai ...
Nature 600 (7889), 472-477, 2021
7482021
Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID): a UK multicentre, prospective cohort study
RA Evans, H McAuley, EM Harrison, A Shikotra, A Singapuri, M Sereno, ...
The Lancet Respiratory Medicine 9 (11), 1275-1287, 2021
5032021
Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study
RA Evans, OC Leavy, M Richardson, O Elneima, HJC McAuley, ...
The Lancet Respiratory Medicine 10 (8), 761-775, 2022
3122022
Co-infections, secondary infections, and antimicrobial use in patients hospitalised with COVID-19 during the first pandemic wave from the ISARIC WHO CCP-UK study: a multicentre …
CD Russell, CJ Fairfield, TM Drake, L Turtle, RA Seaton, DG Wootton, ...
The Lancet Microbe 2 (8), e354-e365, 2021
2972021
Development and validation of the ISARIC 4C Deterioration model for adults hospitalised with COVID-19: a prospective cohort study
RK Gupta, EM Harrison, A Ho, AB Docherty, SR Knight, M van Smeden, ...
The Lancet Respiratory Medicine 9 (4), 349-359, 2021
2212021
Risk of adverse outcomes in patients with underlying respiratory conditions admitted to hospital with COVID-19: a national, multicentre prospective cohort study using the …
CI Bloom, TM Drake, AB Docherty, BJ Lipworth, SL Johnston, ...
The Lancet Respiratory Medicine 9 (7), 699-711, 2021
1712021
Genome-wide CRISPR screen identifies host dependency factors for influenza A virus infection
B Li, SM Clohisey, BS Chia, B Wang, A Cui, T Eisenhaure, LD Schweitzer, ...
Nature communications 11 (1), 164, 2020
1702020
A prenylated dsRNA sensor protects against severe COVID-19
A Wickenhagen, E Sugrue, S Lytras, S Kuchi, M Noerenberg, ML Turnbull, ...
Science 374 (6567), eabj3624, 2021
1532021
Characterisation of in-hospital complications associated with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol UK: a prospective, multicentre cohort study
TM Drake, AM Riad, CJ Fairfield, C Egan, SR Knight, R Pius, ...
The Lancet 398 (10296), 223-237, 2021
1502021
Pleiotropic impacts of macrophage and microglial deficiency on development in rats with targeted mutation of the Csf1r locus
C Pridans, A Raper, GM Davis, J Alves, KA Sauter, L Lefevre, T Regan, ...
The Journal of Immunology 201 (9), 2683-2699, 2018
1102018
Host susceptibility to severe influenza A virus infection
S Clohisey, JK Baillie
Critical Care 23 (1), 1-10, 2019
1032019
Changes in in-hospital mortality in the first wave of COVID-19: a multicentre prospective observational cohort study using the WHO Clinical Characterisation Protocol UK
AB Docherty, RH Mulholland, NI Lone, CP Cheyne, D De Angelis, ...
The Lancet Respiratory Medicine 9 (7), 773-785, 2021
1002021
Non-steroidal anti-inflammatory drug use and outcomes of COVID-19 in the ISARIC Clinical Characterisation Protocol UK cohort: a matched, prospective cohort study
TM Drake, CJ Fairfield, R Pius, SR Knight, L Norman, M Girvan, ...
The Lancet Rheumatology 3 (7), e498-e506, 2021
882021
COVID-19 symptoms at hospital admission vary with age and sex: results from the ISARIC prospective multinational observational study
Infection 49 (5), 889-905, 2021
862021
SARS-CoV-2-specific nasal IgA wanes 9 months after hospitalisation with COVID-19 and is not induced by subsequent vaccination
F Liew, S Talwar, A Cross, BJ Willett, S Scott, N Logan, MK Siggins, ...
EBioMedicine 87, 2023
732023
The impact of viral mutations on recognition by SARS-CoV-2 specific T cells
TI de Silva, G Liu, BB Lindsey, D Dong, SC Moore, NS Hsu, D Shah, ...
Iscience 24 (11), 2021
632021
Macrophage colony-stimulating factor (CSF1) controls monocyte production and maturation and the steady-state size of the liver in pigs
KA Sauter, LA Waddell, ZM Lisowski, R Young, L Lefevre, GM Davis, ...
American Journal of Physiology-Gastrointestinal and Liver Physiology 311 (3 …, 2016
512016
The system can't perform the operation now. Try again later.
Articles 1–20